Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)

Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, Triantafyllos Doskas, Damianos Petrou, Nikolaos Makris, Nikolaos Vlaikidis, Thomas Thomaidis, Athanasios Kyritsis, Nikolaos Fakas, Xoulietta Treska, Clementine Karageorgiou, Stefania Sotirli, Christos Giannoulis, Dimitra Papadimitriou, Ioannis Mylonas, Evaggelos Kouremenos, Georgios Vlachos, Dimitrios Georgiopoulos, Despoina Mademtzoglou & 2 others Michalis Vikelis, Elias Zintzaras

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. The aim of the present study was to evaluate the health care resource use of MS patients under interferon beta-1b (EXTAVIA) treatment in Greece, the demographic or clinical factors that may affect this use and also patient satisfaction with the health care system. Structured interviews were conducted for data collection. In total, 204 patients (74.02% females, mean age (SD) 43.58 (11.42) years) were enrolled in the study. Analysis of the reported data revealed that during the previous year patients made extensive use of health services in particular neurologists (71.08% visited neurologists in public hospitals, 66.67% in private offices and 48.53% in insurance institutes) and physiotherapists. However, the majority of the patients (52.45%) chose as their treating doctor private practice neurologists, which may reflect accessibility barriers or low quality health services in the public health system. Patients seemed to be generally satisfied with the received health care, support and information on MS (84.81% were satisfied from the information provided to them). Patients' health status (as denoted by disease duration, disability status and hospitalization needs) and insurance institute were found to influence their visits to neurologists. Good adherence (up to 70.1%) to the study medication was reported. Patients' feedback on currently provided health services could direct these services towards the patients' expectations.

Original languageEnglish (US)
Article numbere113933
JournalPloS one
Volume9
Issue number11
DOIs
StatePublished - Nov 24 2014

Fingerprint

interferon-beta
sclerosis
observational studies
Health care
health services
Multiple Sclerosis
Health Services
Observational Studies
Patient Care
demographic statistics
Economics
Demography
economics
Health
Insurance
Delivery of Health Care
Therapeutics
United States Public Health Service
insurance
Public health

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA). / Hadjigeorgiou, Georgios; Dardiotis, Efthimios; Tsivgoulis, Georgios; Doskas, Triantafyllos; Petrou, Damianos; Makris, Nikolaos; Vlaikidis, Nikolaos; Thomaidis, Thomas; Kyritsis, Athanasios; Fakas, Nikolaos; Treska, Xoulietta; Karageorgiou, Clementine; Sotirli, Stefania; Giannoulis, Christos; Papadimitriou, Dimitra; Mylonas, Ioannis; Kouremenos, Evaggelos; Vlachos, Georgios; Georgiopoulos, Dimitrios; Mademtzoglou, Despoina; Vikelis, Michalis; Zintzaras, Elias.

In: PloS one, Vol. 9, No. 11, e113933, 24.11.2014.

Research output: Contribution to journalArticle

Hadjigeorgiou, G, Dardiotis, E, Tsivgoulis, G, Doskas, T, Petrou, D, Makris, N, Vlaikidis, N, Thomaidis, T, Kyritsis, A, Fakas, N, Treska, X, Karageorgiou, C, Sotirli, S, Giannoulis, C, Papadimitriou, D, Mylonas, I, Kouremenos, E, Vlachos, G, Georgiopoulos, D, Mademtzoglou, D, Vikelis, M & Zintzaras, E 2014, 'Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)', PloS one, vol. 9, no. 11, e113933. https://doi.org/10.1371/journal.pone.0113933
Hadjigeorgiou, Georgios ; Dardiotis, Efthimios ; Tsivgoulis, Georgios ; Doskas, Triantafyllos ; Petrou, Damianos ; Makris, Nikolaos ; Vlaikidis, Nikolaos ; Thomaidis, Thomas ; Kyritsis, Athanasios ; Fakas, Nikolaos ; Treska, Xoulietta ; Karageorgiou, Clementine ; Sotirli, Stefania ; Giannoulis, Christos ; Papadimitriou, Dimitra ; Mylonas, Ioannis ; Kouremenos, Evaggelos ; Vlachos, Georgios ; Georgiopoulos, Dimitrios ; Mademtzoglou, Despoina ; Vikelis, Michalis ; Zintzaras, Elias. / Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA). In: PloS one. 2014 ; Vol. 9, No. 11.
@article{762c7fe09fe24d718528e4c5ce603c85,
title = "Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)",
abstract = "Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. The aim of the present study was to evaluate the health care resource use of MS patients under interferon beta-1b (EXTAVIA) treatment in Greece, the demographic or clinical factors that may affect this use and also patient satisfaction with the health care system. Structured interviews were conducted for data collection. In total, 204 patients (74.02{\%} females, mean age (SD) 43.58 (11.42) years) were enrolled in the study. Analysis of the reported data revealed that during the previous year patients made extensive use of health services in particular neurologists (71.08{\%} visited neurologists in public hospitals, 66.67{\%} in private offices and 48.53{\%} in insurance institutes) and physiotherapists. However, the majority of the patients (52.45{\%}) chose as their treating doctor private practice neurologists, which may reflect accessibility barriers or low quality health services in the public health system. Patients seemed to be generally satisfied with the received health care, support and information on MS (84.81{\%} were satisfied from the information provided to them). Patients' health status (as denoted by disease duration, disability status and hospitalization needs) and insurance institute were found to influence their visits to neurologists. Good adherence (up to 70.1{\%}) to the study medication was reported. Patients' feedback on currently provided health services could direct these services towards the patients' expectations.",
author = "Georgios Hadjigeorgiou and Efthimios Dardiotis and Georgios Tsivgoulis and Triantafyllos Doskas and Damianos Petrou and Nikolaos Makris and Nikolaos Vlaikidis and Thomas Thomaidis and Athanasios Kyritsis and Nikolaos Fakas and Xoulietta Treska and Clementine Karageorgiou and Stefania Sotirli and Christos Giannoulis and Dimitra Papadimitriou and Ioannis Mylonas and Evaggelos Kouremenos and Georgios Vlachos and Dimitrios Georgiopoulos and Despoina Mademtzoglou and Michalis Vikelis and Elias Zintzaras",
year = "2014",
month = "11",
day = "24",
doi = "10.1371/journal.pone.0113933",
language = "English (US)",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)

AU - Hadjigeorgiou, Georgios

AU - Dardiotis, Efthimios

AU - Tsivgoulis, Georgios

AU - Doskas, Triantafyllos

AU - Petrou, Damianos

AU - Makris, Nikolaos

AU - Vlaikidis, Nikolaos

AU - Thomaidis, Thomas

AU - Kyritsis, Athanasios

AU - Fakas, Nikolaos

AU - Treska, Xoulietta

AU - Karageorgiou, Clementine

AU - Sotirli, Stefania

AU - Giannoulis, Christos

AU - Papadimitriou, Dimitra

AU - Mylonas, Ioannis

AU - Kouremenos, Evaggelos

AU - Vlachos, Georgios

AU - Georgiopoulos, Dimitrios

AU - Mademtzoglou, Despoina

AU - Vikelis, Michalis

AU - Zintzaras, Elias

PY - 2014/11/24

Y1 - 2014/11/24

N2 - Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. The aim of the present study was to evaluate the health care resource use of MS patients under interferon beta-1b (EXTAVIA) treatment in Greece, the demographic or clinical factors that may affect this use and also patient satisfaction with the health care system. Structured interviews were conducted for data collection. In total, 204 patients (74.02% females, mean age (SD) 43.58 (11.42) years) were enrolled in the study. Analysis of the reported data revealed that during the previous year patients made extensive use of health services in particular neurologists (71.08% visited neurologists in public hospitals, 66.67% in private offices and 48.53% in insurance institutes) and physiotherapists. However, the majority of the patients (52.45%) chose as their treating doctor private practice neurologists, which may reflect accessibility barriers or low quality health services in the public health system. Patients seemed to be generally satisfied with the received health care, support and information on MS (84.81% were satisfied from the information provided to them). Patients' health status (as denoted by disease duration, disability status and hospitalization needs) and insurance institute were found to influence their visits to neurologists. Good adherence (up to 70.1%) to the study medication was reported. Patients' feedback on currently provided health services could direct these services towards the patients' expectations.

AB - Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. The aim of the present study was to evaluate the health care resource use of MS patients under interferon beta-1b (EXTAVIA) treatment in Greece, the demographic or clinical factors that may affect this use and also patient satisfaction with the health care system. Structured interviews were conducted for data collection. In total, 204 patients (74.02% females, mean age (SD) 43.58 (11.42) years) were enrolled in the study. Analysis of the reported data revealed that during the previous year patients made extensive use of health services in particular neurologists (71.08% visited neurologists in public hospitals, 66.67% in private offices and 48.53% in insurance institutes) and physiotherapists. However, the majority of the patients (52.45%) chose as their treating doctor private practice neurologists, which may reflect accessibility barriers or low quality health services in the public health system. Patients seemed to be generally satisfied with the received health care, support and information on MS (84.81% were satisfied from the information provided to them). Patients' health status (as denoted by disease duration, disability status and hospitalization needs) and insurance institute were found to influence their visits to neurologists. Good adherence (up to 70.1%) to the study medication was reported. Patients' feedback on currently provided health services could direct these services towards the patients' expectations.

UR - http://www.scopus.com/inward/record.url?scp=84912553379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912553379&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0113933

DO - 10.1371/journal.pone.0113933

M3 - Article

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e113933

ER -